WHO guidelines involve manufacturers to put into action a continuous chance management procedure for sterility test isolators, which includes frequent threat assessments and the development of hazard-centered Regulate strategies. The chance management procedure begins with a radical Assessment of likely failure modes and their likely impacts on sterility assurance. waiting for link from Forum Profiles (6)